Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Menopause (New York, N.Y.)|June 21, 2012
Luteinizing hormone correlates with adrenal function in postmenopausal womenAditi R Saxena, Ellen W Seely
Environmental Health : a Global Access Science Source|February 7, 2014
Gender and racial/ethnic differences in the associations of urinary phthalate metabolites with markers of diabetes risk: National Health and Nutrition Examination Survey 2001-2008Tianyi Huang, Aditi R Saxena, Elvira Isganaitis, et al.
Clinical Therapeutics|January 23, 2023
Inhibition of Diacylglycerol Acyltransferase 2 Versus Diacylglycerol Acyltransferase 1: Potential Therapeutic Implications of PharmacologyNeeta B Amin, Aditi R Saxena, Veena Somayaji, et al.
Environmental Health : a Global Access Science Source|April 16, 2016
The association between phthalates and metabolic syndrome: the National Health and Nutrition Examination Survey 2001-2010Tamarra M James-Todd, Tianyi Huang, Ellen W Seely, et al.
Obesity Science & Practice|June 14, 2021
Energy intake as a short-term biomarker for weight loss in adults with obesity receiving liraglutide: A randomized trialAditi R Saxena, Anindita Banerjee, Karen D Corbin, et al.
Diabetes, Obesity & Metabolism|May 16, 2024
Once-daily oral small-molecule glucagon-like peptide-1 receptor agonist lotiglipron (PF-07081532) for type 2 diabetes and obesity: Two randomized, placebo-controlled, multiple-ascending-dose Phase 1 studiesClare Buckeridge, Nikolaos Tsamandouras, Santos Carvajal-Gonzalez, et al.
Clinical Pharmacology in Drug Development|February 18, 2020
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Liver-Targeting Acetyl-CoA Carboxylase Inhibitor (PF-05221304): A Three-Part Randomized Phase 1 StudyArthur Bergman, Santos Carvajal-Gonzalez, Sanela Tarabar, et al.
Diabetes, Obesity & Metabolism|November 26, 2022
A phase 1 study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of danuglipron (PF-06882961), an oral small-molecule glucagon-like peptide-1 receptor agonist, in Japanese adults with type 2 diabetes mellitusRyosuke Ono, Kenichi Furihata, Yoshihiko Ichikawa, et al.
Hypertension (Dallas, Tex. : 1979)|March 24, 2010
Increased sensitivity to angiotensin II is present postpartum in women with a history of hypertensive pregnancyAditi R Saxena, S Ananth Karumanchi, Nancy J Brown, et al.
Diabetes, Obesity & Metabolism|December 14, 2022
A phase 2a, randomized, double-blind, placebo-controlled, three-arm, parallel-group study to assess the efficacy, safety, tolerability and pharmacodynamics of PF-06835919 in patients with non-alcoholic fatty liver disease and type 2 diabetesAditi R Saxena, Stephanie-An Lyle, Kaivan Khavandi, et al.
Pageof 3